首页> United European gastroenterology journal> Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice-Real-world evidence from the inflammatory bowel diseases-podcast study.

Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice-Real-world evidence from the inflammatory bowel diseases-podcast study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ferdinando,D'Amico

第一单位： Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy.;Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

作者： Ferdinando,D'Amico ^[1] ; Fernando,Gomollón ^[2] ; Giorgos,Bamias ^[3] ; Fernando,Magro ^[4] ; Laura,Targownik ^[5] ; Claudia,Leitner ^[6] ; Tobias,Heatta-Speicher ^[6] ; Naiara,Michelena ^[6] ; Stefanie,Kolterer ^[6] ; Jennifer,Lapthorn ^[7] ; Laura,Kauffman ^[7] ; Axel,Dignass ^[8] ; IBD PODCAST investigators

作者单位： Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy.;Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy. ^[1] Facultad de Medicina, IIS Aragón, Hospital Clínico Universitario "Lozano Blesa", CIBEREHD, Zaragoza, Spain. ^[2] GI-Unit, 3rd Academic Department of Internal Medicine, Sotiria Hospital, National & Kapodistrian University of Athens, Athens, Greece. ^[3] CINTESIS@RISE Departament, Faculdade de Medicina da Universidade do Porto, Porto, Portugal. ^[4] Division of Gastroenterology and Hepatology, Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada. ^[5] AbbVie Inc., North Chicago, Illinois, USA. ^[6] Market Access and HEOR Services, Fortrea, Burlington, North Carolina, USA. ^[7] Department of Medicine I, Agaplesion Markus Hospital, Goethe University, Frankfurt am Main, Germany. ^[8]

关键词 Crohn's disease STRIDE II recommendations extraintestinal manifestations fistula inflammatory bowel diseases quality of life steroid treat to target strategy ulcerative colitis